T0	KEYPHRASE-NOTYPES 4 8	fact
T1	KEYPHRASE-NOTYPES 14 16	LM
T2	KEYPHRASE-NOTYPES 21 23	VM
T3	KEYPHRASE-NOTYPES 65 71	months
T4	KEYPHRASE-NOTYPES 84 93	confusion
T5	KEYPHRASE-NOTYPES 97 106	diagnosis
T6	KEYPHRASE-NOTYPES 111 117	errors
T7	KEYPHRASE-NOTYPES 121 131	management
T8	KEYPHRASE-NOTYPES 137 144	failure
T9	KEYPHRASE-NOTYPES 156 173	effective therapy
T10	KEYPHRASE-NOTYPES 178 180	LM
T11	KEYPHRASE-NOTYPES 185 217	unnecessary antibiotic treatment
T12	KEYPHRASE-NOTYPES 222 224	VM
T13	KEYPHRASE-NOTYPES 227 243	Rapid techniques
T14	KEYPHRASE-NOTYPES 248 257	diagnosis
T15	KEYPHRASE-NOTYPES 261 263	VM
T16	KEYPHRASE-NOTYPES 280 302	appropriate management
T17	KEYPHRASE-NOTYPES 312 327	technology
T18	KEYPHRASE-NOTYPES 357 366	diagnosis
T19	KEYPHRASE-NOTYPES 370 372	LM
T20	KEYPHRASE-NOTYPES 400 407	finding
T21	KEYPHRASE-NOTYPES 411 426	CSF pleocytosis
T22	KEYPHRASE-NOTYPES 447 457	occurrence
T23	KEYPHRASE-NOTYPES 461 463	EM
T24	KEYPHRASE-NOTYPES 471 495	positive serologic tests
T25	KEYPHRASE-NOTYPES 511 529	enzyme immunoassay
T26	KEYPHRASE-NOTYPES 534 552	western blot tests
T27	KEYPHRASE-NOTYPES 557 565	antibody
T28	KEYPHRASE-NOTYPES 608 617	infection
T29	KEYPHRASE-NOTYPES 623 636	dissemination
T30	KEYPHRASE-NOTYPES 644 658	nervous system
T31	KEYPHRASE-NOTYPES 677 683	delays
T32	KEYPHRASE-NOTYPES 717 722	tests
T33	KEYPHRASE-NOTYPES 735 741	delays
T34	KEYPHRASE-NOTYPES 758 767	diagnosis
T35	KEYPHRASE-NOTYPES 772 781	treatment
T36	KEYPHRASE-NOTYPES 788 807	specific techniques
T37	KEYPHRASE-NOTYPES 823 825	LM
T38	KEYPHRASE-NOTYPES 834 839	tests
T39	KEYPHRASE-NOTYPES 844 866	intrathecal production
T40	KEYPHRASE-NOTYPES 870 889	specific antibody16
T41	KEYPHRASE-NOTYPES 897 910	demonstration
T42	KEYPHRASE-NOTYPES 935 938	DNA
T43	KEYPHRASE-NOTYPES 942 967	polymerase chain reaction
T44	KEYPHRASE-NOTYPES 989 1019	polymerase chain reaction test
